MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling

Abstract Previous studies have indicated that Zinc ribbon domain‐containing 1 (ZNRD1) is attributed to the carcinogenesis of human tumors. However, the role of ZNRD1 and its regulation in hepatocellular carcinoma (HCC) are still largely unclear. In this study, we examined the expression profiles of...

Full description

Bibliographic Details
Main Authors: Xiaobo Hu, Ruifang Wang, Zhigang Ren, Xiaorui Liu, Junsheng Gu, Guangying Cui, Qinggang Li
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2613
_version_ 1828779805690036224
author Xiaobo Hu
Ruifang Wang
Zhigang Ren
Xiaorui Liu
Junsheng Gu
Guangying Cui
Qinggang Li
author_facet Xiaobo Hu
Ruifang Wang
Zhigang Ren
Xiaorui Liu
Junsheng Gu
Guangying Cui
Qinggang Li
author_sort Xiaobo Hu
collection DOAJ
description Abstract Previous studies have indicated that Zinc ribbon domain‐containing 1 (ZNRD1) is attributed to the carcinogenesis of human tumors. However, the role of ZNRD1 and its regulation in hepatocellular carcinoma (HCC) are still largely unclear. In this study, we examined the expression profiles of ZNRD1 in HCC tissues by immunohistochemistry (IHC) and publicly datasets analysis. In vitro and in vivo experiments were conducted to identify the function of ZNRD1 in HCC. In addition, miRNA potentially targeting ZNRD1 was predicted by bioinformatics analysis and further verified via in vitro experiments. Our results revealed that ZNRD1 was frequently upregulated in HCC tissues compared with that in nontumor tissues. High ZNRD1 expression in HCC tissues was positively associated with advanced tumor stage and poor prognosis. Function experiments showed that knockdown of ZNRD1 inhibited cell growth and invasion in vitro, and suppressed tumor development in vivo. Moreover, ZNRD1 promoted the activation of Wnt/β‐catenin signaling pathway in HCC. Importantly, miR‐26b directly inhibited the transcription activity of ZNRD1. Overexpression of ZNRD1 dramatically abolished the inhibitory effects of miR‐26b on HCC cells. Taken together, our results uncover a novel mechanistic role for miR‐26b/ZNRD1 axis in HCC, proposing ZNRD1 inhibition as a potent therapeutic strategy for hepatocellular carcinoma.
first_indexed 2024-12-11T17:07:40Z
format Article
id doaj.art-a785330adff6404ba66f3cd8b5f93787
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-12-11T17:07:40Z
publishDate 2019-12-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-a785330adff6404ba66f3cd8b5f937872022-12-22T00:57:38ZengWileyCancer Medicine2045-76342019-12-018177359737110.1002/cam4.2613MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signalingXiaobo Hu0Ruifang Wang1Zhigang Ren2Xiaorui Liu3Junsheng Gu4Guangying Cui5Qinggang Li6Department of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Nuclear Medicine The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaDepartment of Infectious Diseases The First Affiliated Hospital of Zhengzhou University Zhengzhou ChinaAbstract Previous studies have indicated that Zinc ribbon domain‐containing 1 (ZNRD1) is attributed to the carcinogenesis of human tumors. However, the role of ZNRD1 and its regulation in hepatocellular carcinoma (HCC) are still largely unclear. In this study, we examined the expression profiles of ZNRD1 in HCC tissues by immunohistochemistry (IHC) and publicly datasets analysis. In vitro and in vivo experiments were conducted to identify the function of ZNRD1 in HCC. In addition, miRNA potentially targeting ZNRD1 was predicted by bioinformatics analysis and further verified via in vitro experiments. Our results revealed that ZNRD1 was frequently upregulated in HCC tissues compared with that in nontumor tissues. High ZNRD1 expression in HCC tissues was positively associated with advanced tumor stage and poor prognosis. Function experiments showed that knockdown of ZNRD1 inhibited cell growth and invasion in vitro, and suppressed tumor development in vivo. Moreover, ZNRD1 promoted the activation of Wnt/β‐catenin signaling pathway in HCC. Importantly, miR‐26b directly inhibited the transcription activity of ZNRD1. Overexpression of ZNRD1 dramatically abolished the inhibitory effects of miR‐26b on HCC cells. Taken together, our results uncover a novel mechanistic role for miR‐26b/ZNRD1 axis in HCC, proposing ZNRD1 inhibition as a potent therapeutic strategy for hepatocellular carcinoma.https://doi.org/10.1002/cam4.2613HCCmiR‐26bWnt/β‐catenin signaling pathwayZNRD1
spellingShingle Xiaobo Hu
Ruifang Wang
Zhigang Ren
Xiaorui Liu
Junsheng Gu
Guangying Cui
Qinggang Li
MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
Cancer Medicine
HCC
miR‐26b
Wnt/β‐catenin signaling pathway
ZNRD1
title MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
title_full MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
title_fullStr MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
title_full_unstemmed MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
title_short MiR‐26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β‐catenin signaling
title_sort mir 26b suppresses hepatocellular carcinoma development by negatively regulating znrd1 and wnt β catenin signaling
topic HCC
miR‐26b
Wnt/β‐catenin signaling pathway
ZNRD1
url https://doi.org/10.1002/cam4.2613
work_keys_str_mv AT xiaobohu mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT ruifangwang mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT zhigangren mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT xiaoruiliu mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT junshenggu mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT guangyingcui mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling
AT qinggangli mir26bsuppresseshepatocellularcarcinomadevelopmentbynegativelyregulatingznrd1andwntbcateninsignaling